Protocol No.: WVU010220

Phase I/II Study of Neoadjuvant FOLFIRINOX in Combination with Peri-Operative Oral Hydroxychloroquine (FHQ) in Subjects with Resectable Adenocarcinoma of the Pancreas
Principal Investigator
Boone, Brian
Phase
I/II
Age Group
Adult
Applicable Disease Site
Gastrointestinal Cancers
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Meg Zafiris
Research Specialist

View on ClinicalTrials.gov